Loading clinical trials...
Loading clinical trials...
Evaluation of the Effects of Articaine and Bupivacaine in Impacted Third Molar Tooth Surgery
Articaine is a common local anesthetic used in oral surgery and belongs to the amide group of it has fast onset with little side effects. Bupivacaine is preferred in prolonged surgical procedures with its long duration of action and residual analgesic effect. The aim of this study was to evaluate the anesthetic, analgesic, hemodynamic effects of 4% articaine and 0.5% bupivacaine in extraction of impacted mandibular third molar teeth in intraoperative and postoperative periods. Hemodynamic parameters, onset of anesthetic action, total amount, intraoperative comfort, intraoperative bleeding, duration of postoperative anesthesia and analgesia, rescue analgesic use, maximum incisal opening and postoperative pain at 6th, 12th, 24th, 48th and 72th hours and 7th day using a visual analogue scale be evaluated.
Age
18 - 25 years
Sex
ALL
Healthy Volunteers
Yes
Kocaeli University Faculty of Dentistry
Kocaeli, Basiskele, Turkey (Türkiye)
Start Date
December 1, 2018
Primary Completion Date
February 25, 2019
Completion Date
February 25, 2019
Last Updated
November 27, 2020
25
ACTUAL participants
Impacted tooth surgery
PROCEDURE
Lead Sponsor
Kocaeli University
NCT06320665
NCT06514222
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07436546